Global Cord Blood Corp (CORBF)
OTCMKTS: CORBF · Delayed Price · USD
1.000
0.00 (0.00%)
Jul 2, 2024, 12:00 AM EDT - Market closed
Global Cord Blood Market Cap
Global Cord Blood has a market cap or net worth of $133.92 million as of July 3, 2024. Its market cap has decreased by -75.94% in one year.
Market Cap
133.92M
Enterprise Value
-782.29M
1-Year Change
-75.94%
Ranking
n/a
Category
Stock Price
$1.00
Market Cap Chart
Since May 14, 2007, Global Cord Blood's market cap has decreased from $663.70M to $133.92M, a decrease of -79.82%. That is a compound annual growth rate of -9.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2022 | 363.20M | -28.69% |
| Dec 31, 2021 | 509.30M | 12.80% |
| Dec 31, 2020 | 451.50M | -25.72% |
| Dec 31, 2019 | 607.80M | -22.01% |
| Dec 31, 2018 | 779.30M | -31.01% |
| Dec 29, 2017 | 1.13B | 130.48% |
| Dec 30, 2016 | 490.10M | -3.92% |
| Dec 31, 2015 | 510.10M | 54.58% |
| Dec 31, 2014 | 330.00M | 12.74% |
| Dec 31, 2013 | 292.70M | 53.33% |
| Dec 31, 2012 | 190.90M | -4.45% |
| Dec 30, 2011 | 199.80M | -25.53% |
| Dec 31, 2010 | 268.30M | -30.38% |
| Dec 31, 2009 | 385.40M | -43.07% |
| Dec 31, 2007 | 677.00M | 2.00% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 868.86B |
| Novo Nordisk | 643.38B |
| UnitedHealth Group | 454.85B |
| Johnson & Johnson | 352.39B |
| Merck & Co. | 323.90B |
| AbbVie | 300.80B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |